Jennifer Hamilton, the chair of CQDM’s Scientific Advisory Board, is a seasoned life sciences executive with extensive experience across major pharmaceutical companies, global venture capital funds, and biotechnology companies. Most recently, she spent 11 years at Johnson & Johnson Innovation, as country lead responsible for search & evaluation and transactions in Canada. In that role, she scoured universities, incubators, and companies for technologies of interest to Johnson & Johnson and coordinated and monitored research collaborations and license agreements. Prior to that, she spent 15 years in venture capital with Nomura Phase4 Ventures and Rothschild Asset Management. Jennifer has a Ph.D. in experimental pathology from the University of British Columbia. With deep expertise in life sciences ecosystem, spanning both SMEs and large pharmaceutical companies, she is committed to driving innovation and strategic growth in the sector.
